Halberd Corp (HALB) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
P.O. BOX 25 JACKSON CENTER, PA 16133 |
| State of Incorp. | NV |
| Fiscal Year End | July 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 4/30/2022 Q3 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | |||
| Cash and cash equivalent | |||
| Prepaid expense | |||
| Total current assets: | |||
| Noncurrent Assets | |||
| Property, plant and equipment | |||
| Total noncurrent assets: | |||
| TOTAL ASSETS: | |||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | |||
| Accounts payable | |||
| Accrued liabilities | |||
| Debt | |||
| Total current liabilities: | |||
| Noncurrent Liabilities | |||
| Other undisclosed noncurrent liabilities | |||
| Total noncurrent liabilities: | |||
| Total liabilities: | |||
| Equity | |||
| Equity, attributable to parent | |||
| Preferred stock | |||
| Common stock | |||
| Additional paid in capital | |||
| Accumulated deficit | |||
| Total equity: | |||
| TOTAL LIABILITIES AND EQUITY: | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 4/30/2022 Q3 | ||
|---|---|---|
| Revenues | ||
| Gross profit: | ||
| Operating expenses | ||
| Operating loss: | ||
| Nonoperating expense (Other Nonoperating expense) | ||
| Interest and debt expense | ||
| Loss from continuing operations: | ||
| Loss before gain (loss) on sale of properties: | ||
| Net loss: | ||
| Other undisclosed net income attributable to parent | ||
| Net loss available to common stockholders, diluted: | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 4/30/2022 Q3 | ||
|---|---|---|
| Net loss: | ||
| Comprehensive loss, net of tax, attributable to parent: | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.